Cargando…
Two Cases of Atezolizumab-Induced Hypophysitis
Cancer immunotherapy has emerged as treatment of multiple advanced cancer types. Immune checkpoint inhibitors, namely anticytotoxic T-lymphocyte antigen-4 (CTLA-4), antiprogrammed cell death-1 (PD-1), and antiprogrammed cell death-1 ligand 1 (PD-L1) antibodies, have been used for treatment of variou...
Autores principales: | Kanie, Keitaro, Iguchi, Genzo, Bando, Hironori, Fujita, Yasunori, Odake, Yukiko, Yoshida, Kenichi, Matsumoto, Ryusaku, Fukuoka, Hidenori, Ogawa, Wataru, Takahashi, Yutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774896/ https://www.ncbi.nlm.nih.gov/pubmed/29362727 http://dx.doi.org/10.1210/js.2017-00414 |
Ejemplares similares
-
Mechanistic insights into immune checkpoint inhibitor-related hypophysitis: a form of paraneoplastic syndrome
por: Kanie, Keitaro, et al.
Publicado: (2021) -
Two Cases of anti–PIT-1 Hypophysitis Exhibited as a Form of Paraneoplastic Syndrome not Associated With Thymoma
por: Kanie, Keitaro, et al.
Publicado: (2020) -
Clinical Heterogeneity of Acquired Idiopathic Isolated Adrenocorticotropic Hormone Deficiency
por: Fujita, Yasunori, et al.
Publicado: (2021) -
IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner
por: Nishizawa, Hitoshi, et al.
Publicado: (2016) -
SAT-LB079 Clinical Heterogeneity of Acquired Idiopathic ACTH Deficiency: A New Classification Based on the Clinical Characteristics and Autoantibodies
por: FUJITA, YASUNORI, et al.
Publicado: (2019)